Correspondence |

Hepatoerythropoietic Porphyria and Familial Porphyria Cutanea Tarda in Spanish Patients: G281E Mutation in the Uroporphyrinogen Decarboxylase Gene

Esteve Darwich, MD; Jordi To-Figueras, PhD; Celia Badenas, PhD; Carmen Herrero, MD
Arch Dermatol. 2010;146(11):1313-1314. doi:10.1001/archdermatol.2010.314.
Text Size: A A A
Published online


Elder  GH Porphyria cutanea tarda and related disorders. Kadish  KMSmith  KMGuilard  Reds.The Porphyrin Handbook: Medical Aspects of Porphyria.14 San Diego, CA Academic Press2003;67- 92
Ged  COzalla  DHerrero  C  et al.  Description of a new mutation in hepatoerythropoietic porphyria and prenatal exclusion of a homozygous fetus. Arch Dermatol 2002;138 (7) 957- 960
Roberts  AGElder  GHDe Salamanca  REHerrero  CLecha  MMascaro  JM A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients. J Invest Dermatol 1995;104 (4) 500- 502
Moran-Jimenez  MJGed  CRomana  M  et al.  Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria. Am J Hum Genet 1996;58 (4) 712- 721
de Verneuil  HGrandchamp  BBeaumont  CPicat  CNordmann  Y Uroporphyrinogen decarboxylase structural mutant (Gly281----Glu) in a case of porphyria. Science 1986;234 (4777) 732- 734
Méndez  MPoblete-Gutiérrez  PGarcíia-Bravo  M  et al.  Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene. Br J Dermatol 2007;157 (3) 501- 507
Badenas  CTo-Figueras  JPhillips  JDWarby  CAMuñoz  CHerrero  C Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives. Clin Genet 2009;75 (4) 346- 353
Phillips  JDWhitby  FGStadtmueller  BMEdwards  CQHill  CPKushner  JP Two novel uroporphyrinogen decarboxylase (URO-D) mutations causing hepatoerythropoietic porphyria (HEP). Transl Res 2007;149 (2) 85- 91
Armstrong  DKSharpe  PCChambers  CRWhatley  SDRoberts  AGElder  GH Hepatoerythropoietic porphyria: a missense mutation in the UROD gene is associated with mild disease and an unusual porphyrin excretion pattern. Br J Dermatol 2004;151 (4) 920- 923
Meguro  KFujita  HIshida  N  et al.  Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria. J Invest Dermatol 1994;102 (5) 681- 685

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles